Navigation Links
Saving Lives of California Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
Date:8/27/2007

ied.

"We encourage patients to come in for skin exams in general, especially during the summer months when people tend to spend a lot of time outdoors in the sun," said Dr. Gross.

If you think you have a mole that may be cancerous, and would like to have it examined, please contact Skin Surgery Medical Group at 858-292-8641. You may also be eligible to participate in the MelaFind trial.

About Skin Surgery Medical Group, Inc.

At Skin Surgery Medical Group physicians and staff are dedicated to providing its patients with the best possible skin care. Dr. Gross at Skin Surgery Medical Group specializes in the following: skin cancer diagnosis and treatment including but not limited to melanoma, basal cell cancer, squamous cell cancer; diagnosis and treatment of moles and melanoma including sentinel node biopsy of lymph nodes; Mohs Surgery of skin cancer; evaluation and treatment of dysplastic nevus syndrome including use of episope evaluation of moles; skin flaps; skin grafts (full thickness and split thickness); cryosurgery for precancer and cancer; skin cancer surgery of lips, nails, ears, eyelids, and scalp; interferon for cancer, warts, and other skin problems. For more information visit http://www.skinsurgerymed.com.

Media Contact:

Erich Sandoval, Lazar Partners

Tel: (212) 867-1762

esandoval@lazarpartners.com


'/>"/>
SOURCE Skin Surgery Medical Group
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Prospective Model Outlined Potential Time and Cost Savings of Once-Monthly Anemia Treatment
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
6. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
7. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
8. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
9. CuraGen Presents Update on Clinical Development Program for Belinostat
10. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
11. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  Chiasma, Inc. (NASDAQ: ... octreotide capsules for the orphan condition acromegaly, today ... June 30, 2015 and provided a corporate update. ... a transformative time for Chiasma, as we successfully ... that our first New Drug Application (NDA) has ...
(Date:8/31/2015)... 2015 A new Transparency ... monitoring and diagnostic devices market stood at US$3.7 ... a value of approximately US$7.0 billion in 2019, ... and 2019. The title of the report is ... Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, Implantable Loop ...
(Date:8/31/2015)... YORK , Aug. 31, 2015  Dipexium Pharmaceuticals, ... focused on the development and commercialization of Locilex® (pexiganan ... today announced plans to participate in four investor conferences ... 2, 2015 at the Sidoti & Company, LLC Emerging ... . David P. Luci , President & ...
Breaking Medicine Technology:Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3
... announces the appointment of Susan C. Stansfield, PhD ... Development. In this position, Dr. Stansfield will have ... clinical trial management services provided to the biopharmaceutical ... proven leadership skills will be pivotal in enhancing ...
... Reportlinker.com announces that a new market research ... E7: The Outlook for Pharmaceuticals to ... The emerging E7 countries represent the ... these countries is huge: they have a ...
Cached Medicine Technology:Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development 2E7: The Outlook for Pharmaceuticals to 2012 2E7: The Outlook for Pharmaceuticals to 2012 3E7: The Outlook for Pharmaceuticals to 2012 4E7: The Outlook for Pharmaceuticals to 2012 5
(Date:9/1/2015)... ... September 01, 2015 , ... SC&H Group, a leading audit, ... being named a “Best of the Best” firm in the U.S., as well as ... “Best of the Best” in the U.S., selected exclusively on performance in specific areas ...
(Date:9/1/2015)... York, NY (PRWEB) , ... September 01, 2015 ... ... that, to date, more than 1,500 investor-families have received permanent green cards (I-829 ... EB-5 projects. , The I-829 petition is the final step of the EB-5 ...
(Date:9/1/2015)... ... September 01, 2015 , ... Éminence ... of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of natural peel solutions ... Calm, and Clear. , Formulated with alpha hydroxy acids and natural active ...
(Date:9/1/2015)... ... September 01, 2015 , ... The ... new patients directly from Practice Perfect to FOTO enabling cost and time savings, ... , Steven Presement, President of Practice Perfect, stated "FOTO is a natural ...
(Date:9/1/2015)... ... , ... A new episode of “Voices In America”, hosted by famous actor ... of arthritis. There are over 100 different types of arthritis. One of the most ... an effort to shed light on this important topic. , Anyone who is nearing ...
Breaking Medicine News(10 mins):Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:FOTO Announces New Integration Partnership with Practice Perfect 2
... Association) recent survey on 3,000 school students finds, they are watching ... year//. ,Eating in front of the TV, will put ... youngsters and shape them to spend more time on it. ... the most popular screen activity, and so teens spend more time ...
... the early stages of the development of the prostate gland ... scientists for the development of the prostate cancer at the ... in an animal model, also demonstrates how the predisposition may ... ,Man-made compounds that can mimic the hormone action of ...
... in Delhi were once again buzzing with activity today ... who called off their nearly three-week-long anti-quota strike late ... were showing signs of normalcy with patients thronging the ... Safdarjung, Maulana Azad Medical College, Ram Manohar Lohia and ...
... recent study conducted by UT Southwestern Medical Center, has ... about the television's potential danger. // It has stated ... that is harmful but the physical danger of falling ... worth of emergency department cases involving children injured by ...
... charities report that funds for wheelchair service from NHS has ... children are losing out their hope due to lack of ... wheelchair with most basic parts, was given due to fund ... Thus it calls for Government a good, established set of ...
... of summer, mosquitoes too are out to suck warm blood. ... a lethal injection of many harmful diseases//. ,The ... offers an ambient atmosphere for mosquito to breed. In his ... in the United States in human population density and we're ...
Cached Medicine News:Health News:Prostate Cancer Risk Linked To Early Estrogen Exposure 2Health News:Adults Needs to be Educated About the Dangers of Elevated TVs 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: